Cariprazine Production Cost Reports

The report provides a detailed analysis essential for establishing a cariprazine production plant. It encompasses all critical aspects necessary for cariprazine production, including the cost of cariprazine production, cariprazine plant cost, cariprazine production costs, and the overall cariprazine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a cariprazine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Cariprazine is an atypical antipsychotic medication primarily used in the treatment of schizophrenia and bipolar disorder. It is effective in managing symptoms such as delusions, hallucinations, and mood swings. It works by balancing certain chemicals in the brain, particularly dopamine and serotonin, which are involved in mood and behaviour regulation. It is prescribed for individuals experiencing episodes of schizophrenia or manic episodes associated with bipolar disorder. It is also used for the treatment of mixed or manic episodes in bipolar I disorder. It is also sometimes utilised for the treatment of agitation in patients with autism spectrum disorder.

The demand for cariprazine is predominantly driven by its application as an antipsychotic drug in treating other mood disorders and conditions related to psychiatric health, which supports its market growth. Its application in the treatment of adult patients with schizophrenia and manic or mixed episodes in bipolar disorder also strengthens its demand in the medical and healthcare sectors. Its demand as an important treatment option for individuals who have not responded well to other antipsychotic drugs further contributes to its market expansion. Its potential for use in other neurological and psychiatric disorders also continues to drive its market growth.

Factors such as the cost of raw materials, regulatory compliance, and the availability of reliable suppliers significantly impact industrial cariprazine procurement. Moreover, advancements in drug formulation technologies, the increasing focus on patient-centric treatments, and sustainable production also impact its market. Efficient logistics and adherence to environmental guidelines are also considered critical factors in maintaining a consistent supply chain for Cariprazine globally.

Raw Material for Cariprazine Production

According to the cariprazine production plant project report, the major raw materials for cariprazine production include 2-(4-nitrophenyl)acetic acid, triphosgene, and dimethylamine.

Production Process of Cariprazine

The extensive cariprazine production cost report consists of the following industrial production process:

1. Production via Hydrogenation: The production process of cariprazine begins with the hydrogenation of 2-(4-nitrophenyl)acetic acid using Pd/C in water, which reduces the nitro group and then the phenyl ring to yield 4-aminocyclohexylacetic acid. Then, this crude aqueous solution is treated with HCl in refluxing ethanol to form the ethyl ester, purified as its HCl salt via crystallisation. The amine is then Boc-protected, the ester reduced to a primary alcohol, mesylated, and alkylated with piperazine to build the piperazinyl cyclohexane intermediate. Finally, the protecting group is removed by acidic ethanolysis, followed by reaction with triphosgene and dimethylamine to form cariprazine freebase. Further, the obtained compound is reacted with methanolic HCl to form cariprazine hydrochloride as the desired product.

Cariprazine is an atypical antipsychotic agent and a piperazine derivative with potent activity at dopamine receptors. It appears as an off-white to light beige solid powder that is slightly soluble in dimethyl sulfoxide and methanol. The molecular formula of the compound is C21H32Cl2N4O, and its molar mass is 427.41 g/mol. It has a density of around 1.24 g/cm3. It is generally stored under an inert atmosphere at -20 degree Celsius in a freezer. The compound is administered orally and is used to treat schizophrenia, manic or mixed episodes associated with bipolar I disorder, and depressive episodes associated with bipolar I disorder. The melting point of the compound is greater than 180 degree Celsius. The most common side effects include nausea, mild sedation, fatigue, dizziness, akathisia, extrapyramidal symptoms, headache, insomnia, and constipation. It is recommended to store the compound at controlled room temperature in a dry, dark environment. Caution should be exercised when handling this compound, and individuals with known hypersensitivity to cariprazine or related compounds should avoid its use.